Generic placeholder image

Current Neuropharmacology

Editor-in-Chief

ISSN (Print): 1570-159X
ISSN (Online): 1875-6190

Review Article

Neuro-regeneration or Repair: Cell Therapy of Neurological Disorders as A Way Forward

Author(s): Xiao-Yan Song, Cun-xiu Fan, Atta-ur Rahman, Muhammad Iqbal Choudhary and Xiao-Ping Wang*

Volume 22, Issue 14, 2024

Published on: 27 June, 2024

Page: [2272 - 2283] Pages: 12

DOI: 10.2174/1570159X22666240509092903

Price: $65

Abstract

The human central nervous system (CNS) has a limited capacity for regeneration and repair, as many other organs do. Partly as a result, neurological diseases are the leading cause of medical burden globally. Most neurological disorders cannot be cured, and primary treatments focus on managing their symptoms and slowing down their progression. Cell therapy for neurological disorders offers several therapeutic potentials and provides hope for many patients. Here we provide a general overview of cell therapy in neurological disorders such as Parkinson’s disease (PD), Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), Wilson’s disease (WD), stroke and traumatic brain injury (TBI), involving many forms of stem cells, including embryonic stem cells and induced pluripotent stem cells. We also address the current concerns and perspectives for the future. Most studies for cell therapy in neurological diseases are in the pre-clinical stage, and there is still a great need for further research to translate neural replacement and regenerative therapies into clinical settings.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy